Zhangzhou Pientzehuang (China) Investor Sentiment

600436 Stock   224.99  1.07  0.47%   
About 62% of Zhangzhou Pientzehuang's investor base is looking to short. The analysis of overall sentiment of trading Zhangzhou Pientzehuang Pharmaceutical stock suggests that many investors are alarmed at this time. The current market sentiment, together with Zhangzhou Pientzehuang's historical and current headlines, can help investors time the market. In addition, many technical investors use Zhangzhou Pientzehuang stock news signals to limit their universe of possible portfolio assets.
  
over two weeks ago at news.google.com         
Zhangzhou Pientzehuang Pharmaceutical., Ltds Share Price Could Signal Some Risk - Simply Wall St
Google News at Macroaxis
over a month ago at news.google.com         
SSE 50 Shanghai Stock Exchange 50 Index - AskTraders
Google News at Macroaxis
over two months ago at news.google.com         
Zhangzhou Pientzehuang Pharmaceutical., Ltds biggest owners are private companies who got richer aft...
Google News at Macroaxis
over three months ago at news.google.com         
Earnings Miss Zhangzhou Pientzehuang Pharmaceutical., Ltd Missed EPS By percent And Analysts Are Rev...
Google News at Macroaxis
over three months ago at news.google.com         
Zhangzhou Pientzehuang Pharmaceutical Second Quarter 2024 Earnings Misses Expectations - Simply Wall...
Google News at Macroaxis
over three months ago at news.google.com         
Investors in Zhangzhou Pientzehuang Pharmaceutical have seen solid returns of 113 percent over the p...
Google News at Macroaxis
over three months ago at news.google.com         
Subdued Growth No Barrier To Zhangzhou Pientzehuang Pharmaceutical., Ltds Price - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Zhangzhou Pientzehuang Pharmaceutical., Ltds last weeks 4.2 percent decline must have disappointed p...
Google News at Macroaxis
over six months ago at news.google.com         
Be Sure To Check Out Zhangzhou Pientzehuang Pharmaceutical., Ltd Before It Goes Ex-Dividend - Simply...
Google News at Macroaxis
over six months ago at news.google.com         
Exclusive Sinopharm-led consortium plans 3.3 billion take-private of HK-listed China TCM - sources -...
Google News at Macroaxis
over six months ago at news.google.com         
Is Zhangzhou Pientzehuang Pharmaceutical., Ltds Recent Stock Performance Tethered To Its Strong ... ...
Google News at Macroaxis
over six months ago at news.google.com         
Zhangzhou Pientzehuang Pharmaceutical First Quarter 2024 Earnings Beats Expectations - Simply Wall S...
Google News at Macroaxis
over six months ago at news.google.com         
Investing in Zhangzhou Pientzehuang Pharmaceutical five years ago would have delivered you a 98 perc...
Google News at Macroaxis
over six months ago at news.google.com         
CNNC Hua Yuan Titanium Dioxide Co., Ltds Stock Has Seen Strong Momentum Does That Call For Deeper St...
Google News at Macroaxis
over six months ago at news.google.com         
Zhangzhou Pientzehuang Pharmaceutical., Ltds biggest owners are private companies who got richer aft...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Zhangzhou Pientzehuang that are available to investors today. That information is available publicly through Zhangzhou media outlets and privately through word of mouth or via Zhangzhou internal channels. However, regardless of the origin, that massive amount of Zhangzhou data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Zhangzhou Pientzehuang news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Zhangzhou Pientzehuang relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Zhangzhou Pientzehuang's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Zhangzhou Pientzehuang alpha.

Zhangzhou Pientzehuang Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Zhangzhou Pientzehuang Pharmaceutical., Ltds Share Price Could Signal Some Risk - Simply Wall St
11/25/2024

Complementary Tools for Zhangzhou Stock analysis

When running Zhangzhou Pientzehuang's price analysis, check to measure Zhangzhou Pientzehuang's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhangzhou Pientzehuang is operating at the current time. Most of Zhangzhou Pientzehuang's value examination focuses on studying past and present price action to predict the probability of Zhangzhou Pientzehuang's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhangzhou Pientzehuang's price. Additionally, you may evaluate how the addition of Zhangzhou Pientzehuang to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance